期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 58, 期 6, 页码 3013-3020出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.02374-13
关键词
-
资金
- NICHD [HHSN2752010000031, K23HD068497]
- National Institutes of Health [U54D071600]
- National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001117]
- U.S. government under Best Pharmaceuticals for Children Act [HHSN267200700051C]
- U.S. government [UL1TR001117, 1R01HD057956-05, 1K24HD058735-05, U54 HD071600-01, U10 HD045934 05]
- U.S. government (NICHD) [HHSN275201000003I]
- Thrasher Research Fund
- industry for neonatal and pediatric drug development
- Trius
- Cerexa Pharmaceuticals
- Abbott
- Theravance
- National Institutes of Health (NIH) [1K23HD064814]
- National Center for Advancing Translational Sciences of the NIH [UL1TR001117]
- Food and Drug Administration [1U01FD004858-01]
- Biomedical Advanced Research and Development Authority (BARDA) [HHSO100201300009C]
- industry for drug development in adults and children
Although ampicillin is the most commonly used drug in neonates, developmental pharmacokinetic (PK) data to guide dosing are lacking. Ampicillin is primarily renally eliminated, and developmental changes are expected to influence PK. We conducted an open-label, multicenter, opportunistic, prospective PK study of ampicillin in neonates stratified by gestational age (GA) (<= 34 or >34 weeks) and postnatal age (PNA) (<= 7 or >7 days). Drug concentrations were measured by tandem mass spectrometry. PK data were analyzed using population nonlinear mixed-effects modeling in NONMEM 7.2. Monte Carlo simulations were conducted to determine the probability of target attainment for the time in which the total steady-state ampicillin concentrations remained above the MIC (T>MIC) for 50%, 75%, and 100% of the dosing interval. A total of 142 PK samples from 73 neonates were analyzed (median [range] GA, 36 [24 to 41] weeks; PNA, 5 [0 to 25] days). The median ampicillin dose was 200 (100 to 350) mg/kg/day. Postmenstrual age and serum creatinine were covariates for ampicillin clearance (CL). A simplified dosing regimen of 50 mg/kg every 12 h for GA of <= 34 weeks and PNA of <= 7 days, 75 mg/kg every 12 h for GA of <= 34 weeks and PNA of >= 8 and <= 28 days, and 50 mg/kg every 8 h for GA of >34 weeks and PNA of <= 28 days achieved the prespecified surrogate efficacy target in 90% of simulated subjects. Ampicillin CL was associated with neonatal development. A simplified dosing regimen stratified by GA and PNA achieves the desired surrogate therapeutic target in the vast majority of neonates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据